PAS
TRML

Point72 Asia (Singapore)’s Tourmaline Bio TRML Stock Holding History

Point72 Asia (Singapore)’s Portfolio TRML Stock Details TRML Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$222K Buy
+4,637
New +$129K 0.03% 277

Other funds holding TRML

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
QUSVM
Qiming U.S. Ventures Management Bellevue, Washington $55.6M AUM 98.09% 1-Year Est. Return
FTCM
First Trust Capital Management Chicago, Illinois $1.9B AUM 58.39% 1-Year Est. Return

Point72 Asia (Singapore)'s TRML Position: Q3 2025 in Review

Point72 Asia (Singapore) opened a new position in Tourmaline Bio (TRML) in Q3 2025: 4,637 shares worth $222K. The stake represents 0.03% of the portfolio and ranks #277 among its holdings.

134 funds tracked by Wall St. Rank hold TRML as of Q3 2025.

  • Point72 Asia (Singapore) held 4,637 shares of Tourmaline Bio worth $222K as of Q3 2025.
  • Tourmaline Bio was a new Point72 Asia (Singapore) position in Q3 2025.
  • Tourmaline Bio made up 0.03% of Point72 Asia (Singapore)'s portfolio in Q3 2025, its #277 holding.
  • 134 funds tracked by Wall St. Rank held Tourmaline Bio as of Q3 2025.

Based on Point72 Asia (Singapore)'s 13F filing for Q3 2025, filed 14 Nov 2025.